These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36712341)

  • 1. Intratumoral nanobody-IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in mice.
    Lutz EA; Jailkhani N; Momin N; Huang Y; Sheen A; Kang BH; Wittrup KD; Hynes RO
    PNAS Nexus; 2022 Nov; 1(5):pgac244. PubMed ID: 36712341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy.
    Jung K; Yoo S; Kim JE; Kim W; Kim YS
    Front Immunol; 2022; 13():1034774. PubMed ID: 36405748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
    Hess C; Neri D
    Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
    Vijayakumar G; McCroskery S; Palese P
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytokines are a promising immunotherapeutic approach against glioblastoma.
    Weiss T; Puca E; Silginer M; Hemmerle T; Pazahr S; Bink A; Weller M; Neri D; Roth P
    Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
    Kaspar M; Trachsel E; Neri D
    Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.
    Xenaki KT; Dorrestijn B; Muns JA; Adamzek K; Doulkeridou S; Houthoff H; Oliveira S; van Bergen En Henegouwen PM
    Theranostics; 2021; 11(11):5525-5538. PubMed ID: 33859761
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors.
    Mortensen MR; Mock J; Bertolini M; Stringhini M; Catalano M; Neri D
    Oncotarget; 2020 Nov; 11(44):3972-3983. PubMed ID: 33216834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy.
    Prodi E; Neri D; De Luca R
    Onco Targets Ther; 2024; 17():697-715. PubMed ID: 39224695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present and future of immunocytokines for cancer treatment.
    Gout DY; Groen LS; van Egmond M
    Cell Mol Life Sci; 2022 Sep; 79(10):509. PubMed ID: 36066630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities.
    Dreier T; Lode HN; Xiang R; Dolman CS; Reisfeld RA; Kang AS
    Bioconjug Chem; 1998; 9(4):482-9. PubMed ID: 9667950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution.
    Tzeng A; Kwan BH; Opel CF; Navaratna T; Wittrup KD
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3320-5. PubMed ID: 25733854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way.
    Yu X; Long Y; Chen B; Tong Y; Shan M; Jia X; Hu C; Liu M; Zhou J; Tang F; Lu H; Chen R; Xu P; Huang W; Ren J; Wan Y; Sun J; Li J; Jin G; Gong L
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36253000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview.
    Boersma B; Poinot H; Pommier A
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of bolus and fractionated administration modalities for two antibody-cytokine fusions in immunocompetent tumor-bearing mice.
    Puca E; De Luca R; Seehusen F; Rodriguez JMM; Neri D
    J Control Release; 2020 Jan; 317():282-290. PubMed ID: 31790729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripokin: A multi-specific immunocytokine for cancer immunotherapy.
    Prodi E; Corbellari R; Ghezzi L; Ciambellotti S; Catastini JE; Rappuoli M; Rotta G; Sakic I; Weiss T; Weller M; Pellegrino C; Manz MG; Neri D; De Luca R
    Int J Cancer; 2025 Jan; 156(1):216-228. PubMed ID: 39177452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties
    Ongaro T; Gouyou B; Stringhini M; Corbellari R; Neri D; Villa A
    Oncotarget; 2020 Oct; 11(41):3698-3711. PubMed ID: 33110477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytokines: a promising approach to cancer immunotherapy.
    Lode HN; Xiang R; Becker JC; Gillies SD; Reisfeld RA
    Pharmacol Ther; 1998 Dec; 80(3):277-92. PubMed ID: 9888698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.